- Delaware federal judge set 30% ongoing royalty to Natera on post-injunction revenue from infringing MRD-related product sales that qualify for exceptions to injunction.
- Ruling issued April 6, 2026; injunction entered Nov. 21, 2023.
- Jury’s effective 20.5% royalty on pre-injunction MRD revenue remains unchanged.
- Court upheld validity of three asserted MRD patents in Natera litigation against ArcherDx, Invitae.
- Verdict finding patent validity, direct infringement for non-MRD products remains intact.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Natera Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 202604090600BIZWIRE_USPR_____20260409_BW795411) on April 09, 2026, and is solely responsible for the information contained therein.
Comments